GnRH agonist therapy in a patient with recurrent ovarian granulosa cell tumors

Journal of Korean Medical Science

Volumn 24, Issue 3, 2009, Pages 535-538

  Kim, Hyun Jung ^a   Lee, Sang Cheol ^a   Bae, Sang Byung ^a   Kwon, Kye Won ^a   Kim, Chan Kyu ^a   Lee, Nam Su ^a   Lee, Kyu Taek ^a   Won, Jong Ho ^a   Hong, Dae Sik ^a   Park, Hee Sook ^a  

^a Soonchunhyang University College of Medicine   (South Korea)

Author keywords

Granulosa cell tumor; Hormone Therapy; Leuprolide

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; GONADORELIN; LEUPRORELIN;

AGED; ARTICLE; CASE REPORT; DRUG POTENTIATION; FEMALE; GRANULOSA CELL TUMOR; HUMAN; METABOLISM; OVARY TUMOR; RADIOGRAPHY; RECURRENT DISEASE;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; FEMALE; GONADOTROPIN-RELEASING HORMONE; GRANULOSA CELL TUMOR; HUMANS; LEUPROLIDE; OVARIAN NEOPLASMS; RECURRENCE;

EID: 67649229485     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2009.24.3.535     Document Type: Article

References (19)

1. Hartmann LC, Young RH, Podratz KC. Ovarian sex cord-stromal tumors. In: Hoskins, Perez CA, Young RC, eds. Principles and practice of gynecologic oncology. 3rd ed. Lippincott Williams and Wilkins; 1993: 1075-93.
2. Miller BE, Barron BA, Dockter ME, Delmore JE, Silva EG, Gershenson DM. Parameters of differentiation and proliferation in adult granulosa cell tumors of the ovary. Cancer Detect Prev 2001; 25: 48-54.
3. Muntz HG, Goff BA, Fuller AF Jr. Recurrent ovarian granulosa cell tumor: role of combination chemotherapy with report of a long-term response to a cyclophosphamide, doxorubicin and cisplatin regimen. Eur J Gynaecol Oncol 1990; 11: 263-8.
4. Wolf JK, Mullen J, Eifel PJ, Burke TW, Levenback C, Gershenson DM. Radiation treatment of advanced or recurrent granulosa cell tumor of the ovary. Gynecol Oncol 1999; 73: 35-41.
5. Kumar PP, Good RR, Linder J. Complete response of granulosa cell tumor metastatic to liver after hepatic irradiation: a case report. Obstet Gynecol 1986; 67 (Suppl 3): 95S-8S.
6. Dubuc-Lissoir J, Berthiaume MJ, Boubez G, Van Nguyen T, Allaire G. Bone metastasis from granulosa cell tumor of the ovary. Gynecol Oncol 2001; 83: 400-4.
7. Fishman A, Kudelka AP, Tresukosol D, Edwards CL, Freedman RS, Kaplan AL, Girtanner RE, Kavanagh JJ. Leuprolide acetate for treating refractory or persistent ovarian granulosa cell tumor. J Reprod Med 1996; 41: 393-6.
8. Kauppila A, Bangah M, Burger H, Martikainen H. GnRH agonist analog therapy in advanced/recurrent granulosa cell tumors: further evidence of a role of inhibin in monitoring response to treatment. Gynecol Endocrinol 1992; 6: 271-4.
9. Maxwell GL, Soisson AP, Miles P. Failure of gonadotropin releasing hormone therapy in patients with metastatic ovarian sex cord stromal tumors. Oncology 1994; 51: 356-9.
10. Freeman SA, Modesitt SC. Anastrozole therapy in recurrent ovarian adult granulosa cell tumors: a report of 2 cases. Gynecol Oncol 2006; 103: 755-8.
11. Malik ST, Slevin ML. Medroxyprogesterone acetate (MPA) in advanced granulosa cell tumours of the ovary-- a new therapeutic approach? Br J Cancer 1991; 63: 410-1.
12. Liu J, Hyden-Granskog C, Voutilainen R. Gonadotrophins inhibit and activin induces expression of inhibin/activin beta(B) subunit mRNA in cultured human granulosa-luteal cells. Mol Hum Reprod 2001; 7: 319-23.
13. Lovell TM, Gladwell RT, Groome NP, Knight PG. Modulatory effects of gonadotrophins and insulin-like growth factor on the secretion of inhibin A and progesterone by granulosa cells from chicken preovulatory (F1-F3) follicles. Reproduction 2002; 123: 291-300.
14. Meyer JS, Rao BR, Valdes R Jr, Burstein R, Wasserman HC. Progesterone receptor in granulosa cell tumor. Gynecol Oncol 1982; 13: 252-7.
15. Davy M, Torjesen PA, Aakvaag A. Demonstration of the FSH receptor in a functioning granulosa cell tumour. The effect of gonadotrophin treatment on its viability following transplantation to nude mice. Acta Endocrinol (Copenh) 1977; 85: 615-23.
16. Cook T, Sheridan WP. Development of GnRH antagonists for prostate cancer: new approaches to treatment. Oncologist 2000; 5: 162-8.
17. Robertson JF, Blamey RW. The use of gonadotrophin-releasing hormone (GnRH) agonists in early and advanced breast cancer in preand perimenopausal women. Eur J Cancer 2003; 39: 861-9.
18. Rodriquez G. New insights regarding pharmacologic approaches for ovarian cancer prevention. Hematol Oncol Clin North Am 2003; 17: 1007-20.
19. Rey RA, Lhomme C, Marcillac I, Lahlou N, Duvillard P, Josso N, Bidart JM. Antimüllerian hormone as a serum marker of granulosa cell tumors of the ovary: comparative study with serum alpha-inhibin and estradiol. Am J Obstet Gynecol 1996; 174: 958-65.